cannabis europa
cannabis europa · page 2
- Interviews
Voices of Cannabis Europa: Green Success’ Yuval Soiref on the Next Phase of European Cannabis
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis industry for two days of main stage debate, exhibition, and networking.
- Industry Trends
Cannabis Europa London 2026: The First Major Gathering Since Rescheduling Changed the Game
For many, last week’s rescheduling announcement threw a spanner in the works.
- Events
How to Enter the Business of Cannabis Awards 2026, and Give Yourself the Best Chance of Winning
The third annual Business of Cannabis Awards ceremony is fast approaching, and with submissions closing on May 13, time is running out to complete your submissions.
- Events
Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level networking and the 2026 Business of Cannabis Awards Cannabis Europa, the leading B2B conference for the European cannabis industry, today announced the full programme for its 2026 London edition.
- Medical Cannabis
Why Medical Cannabis Clinics Should Be Knocking on Union Doors
When a crew trainer at a fast food restaurant told her manager she had recently been prescribed medical cannabis, she came prepared.
- International Regulation
France’s Budget Chaos Nears Resolution, Removing Major Barrier for Medical Cannabis Rollout
Earlier this week (Tuesday, January 27), France’s government survived two no-confidence votes, finally passing its contentious 2026 budget following months of political crisis that had largely paralysed non-urgent policymaking.
- International Regulation
France’s First Prescriptions ‘Unlikely This Year’ Despite ‘Complete’ Framework
Last week, France’s now five-year old medical cannabis pilot programme was extended once again, providing a bridge beyond March 2026 for patients to continue secure access to their medication.
- Uncategorized
Small Island, Big Vision: Medical Cannabis as a Catalyst for Economic Growth
Most people associate the Isle of Man with its world-famous TT motorcycle races or its well-established financial services sector. But quietly and confidently, our Island is taking bold steps towards building one of Europe’s most exciting and high-potential new industries: medicinal cannabis.
- Uncategorized
Business of Cannabis Awards 2025: We Have Our Winners
The shortlist for the second annual Business of Cannabis Awards, Europe’s leading celebration of excellence across the cannabis sector, have been announced today.
- Uncategorized
Cannabis Europa 2025 – Key Insights Day 1: Part 1
Today, Cannabis Europa 2025 welcomed hundreds of the world’s leading cannabis voices for its first jam packed day of sessions.
- Press releases
Glass Pharms Signs Supply Deal with Mamedica in ‘Milestone for UK Cultivation’
Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use).
- Opinion
‘Europe Risks Legislating Without Execution’: The Entourage Effect CEO on What Europe Needs to Scale
Ahead of the Cannabis Europa 2026, which kicks off next Tuesday (June 24) at the Barbican Centre, we caught up with Eidan Havas, the Founder of one of Australia’s leading medical cannabis product wholesalers, The Entourage Effect.
